| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Joinn Laboratories (China) Co.Ltd (SHG: 603127)
603127 Technical Analysis
5
| As on 12th Jan 2026 603127 STOCK Price closed @ 40.38 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 23.68 & Strong Buy for SHORT-TERM with Stoploss of 17.30 we also expect STOCK to react on Following IMPORTANT LEVELS. |
603127STOCK Price
| Open | 41.50 | Change | Price | % |
| High | 41.55 | 1 Day | -1.73 | -4.11 |
| Low | 39.99 | 1 Week | 5.58 | 16.03 |
| Close | 40.38 | 1 Month | 12.48 | 44.73 |
| Volume | 24912832 | 1 Year | 22.65 | 127.75 |
| 52 Week High 42.20 | 52 Week Low 15.26 | ||||
SHG China Most Active Stocks
| 600010 | 2.69 | 3.46% |
| 601099 | 4.54 | 7.84% |
| 601933 | 5.36 | 3.88% |
| 600157 | 1.66 | -0.60% |
| 600705 | 3.47 | 0.29% |
| 600811 | 0.36 | -2.70% |
| 600759 | 3.60 | 2.56% |
| 601929 | 4.20 | 6.06% |
| 601399 | 6.41 | 3.22% |
| 600050 | 5.49 | 1.29% |
SHG China Top Gainers Stocks
SHG China Top Losers Stocks
| 603127 Daily Charts |
603127 Intraday Charts |
Whats New @ Bazaartrend |
603127 Free Analysis |
|
|
603127 Important Levels Intraday
| RESISTANCE | 43.39 |
| RESISTANCE | 42.42 |
| RESISTANCE | 41.83 |
| RESISTANCE | 41.23 |
| SUPPORT | 39.53 |
| SUPPORT | 38.93 |
| SUPPORT | 38.34 |
| SUPPORT | 37.37 |
603127 Forecast January 2026
| 4th UP Forecast | 45.76 |
| 3rd UP Forecast | 44.03 |
| 2nd UP Forecast | 42.97 |
| 1st UP Forecast | 41.9 |
| 1st DOWN Forecast | 38.86 |
| 2nd DOWN Forecast | 37.79 |
| 3rd DOWN Forecast | 36.73 |
| 4th DOWN Forecast | 35 |
603127 Weekly Forecast
| 4th UP Forecast | 44.58 |
| 3rd UP Forecast | 43.23 |
| 2nd UP Forecast | 42.40 |
| 1st UP Forecast | 41.57 |
| 1st DOWN Forecast | 39.19 |
| 2nd DOWN Forecast | 38.36 |
| 3rd DOWN Forecast | 37.53 |
| 4th DOWN Forecast | 36.18 |
603127 Forecast2026
| 4th UP Forecast | 94.24 |
| 3rd UP Forecast | 76.97 |
| 2nd UP Forecast | 66.29 |
| 1st UP Forecast | 55.61 |
| 1st DOWN Forecast | 25.15 |
| 2nd DOWN Forecast | 14.47 |
| 3rd DOWN Forecast | 3.79 |
| 4th DOWN Forecast | -13.48 |
Joinn Laboratories (China) Co.Ltd ( SHG China Symbol : 603127 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
603127 Other Details
| Segment | EQ | |
| Market Capital | 52484358144.00 | |
| Sector | Healthcare | |
| Industry | Diagnostics & Research | |
| Offical website | > echo $website ; ?> | |
603127 Address
![]() |
||
603127 Latest News
603127 Business Profile
Joinn Laboratories (China) Co., Ltd. provides preclinical and non-clinical services. It evaluates various drugs, including biologics, pharmaceutical chemicals, and plant medicines for indications, such as renal, metabolic, cardiology, hematology, COPD, ophthalmic, oncology, and immune-related diseases. The company's services include screening services, such as efficiency screening, bioavailability, ADME screening, and non-GLP toxicology studies; pre-clinical safety assessment comprising general toxicology, safety pharmacology, developmental and reproductive toxicology, genetic and ocular toxicology, clinical pathology, analytical and bioanalytical analysis, immunology, and biomarker assays; pharmacodynamics services; and services to evaluate and optimize the absorption, distribution, metabolism, and elimination (ADME), as well as pharmacokinetic properties of potential drugs from early discovery projects. Its services also comprise clinical trials; a range of safety assessment services for medical devices, chemicals, and agrochemicals; regulatory consulting services in the areas of pharmaceuticals, biologics, Chinese medicine, medical devices, veterinary medicines, and agrochemicals; and food animal evaluation services comprising candidate selection, efficacy, safety evaluation studies on animals' health products, animal remedies, and fodders. In addition, the company offers traditional animals, such as outbred rats, inbred strain mice, outbred mice, and immunodeficient mice. It serves pharmaceutical, medical device, chemical, biotechnology, and agricultural development companies, as well as regulatory and other government agencies. It serves pharmaceutical, medical device, chemical, biotechnology, and agricultural development companies. The company operates in China, Europe, North America, Southeast Asia, and Australia. The company was founded in 1995 and is based in Beijing, China. Address: No.5 Rongjingdong Street, Beijing, China, 100176
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

